ORDER
This matter comes before the undersigned upon defendant Raster’s motion to dismiss and defendant Angicor’s motion to dismiss, or alternatively for summary judgment. 1 Although the motions were submitted to the court at different times, the court will address both motions in this order because the motions involve common issues of law and fact.
I. BACKGROUND.
Because the respective motions are essentially motions to dismiss, all allegations in the amended complaint are assumed to be true and the motions should be denied unless “it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief.”
Bennett v. Berg,
In its amended complaint, Medical alleges that defendants formulated and implemented a fraudulent scheme to misappropriate Medical’s trade secrets and to wrongfully use such information in competition with Medical. Specifically, plaintiff alleges that while employed with Medical, Raster was privy to Medical’s trade secrets, and that such disclosures were made to Raster only after he agreed not to disclose them to others or to use them himself except in his employment at Medical. Plaintiff further alleges that following termination of his employment with Medical, Raster took or retained Medical’s proprietary information relating to heart valves and subsequently used such confidential information to manufacture and sell heart valves in unfair competition with Medical. Defendants’ alleged use of Medical’s trade secrets allegedly violated several federal statutory laws, including 18 U.S.C. § 1341 (mail fraud), § 1343 (wire fraud), and § 2314 (transportation of stolen goods).
Plaintiff's amended complaint contains four counts. In counts I and II, plaintiff asserts a cause of action under the Racketeer Influenced and Corrupt Organization Act (“RICO”) against Raster and Angicor respectively. In count III, plaintiff asserts a pendant state law claim for misappropriation of trade secrets against both Raster and Angicor. In count IV, plaintiff asserts a pendent state law claim for unjust enrichment against Raster relating to a state court action entitled Regents of the University of Minnesota v. Medical, Inc.
Defendant Raster moves for dismissal of the entire amended complaint as against Raster. Raster argues that plaintiff failed to state a claim with regard to the RICO and misappropriation of trade secrets counts and that plaintiff’s claim of unjust enrichment is collaterally stopped. Alternatively, Raster requests dismissal of the state law claims without prejudice (counts III and IV) under Gibbs if the court dismisses the RICO claims.
Defendant Angicor also moves to dismiss the entire complaint as against Angicor. Like Raster, Angicor argues that plaintiff failed to state a claim under RICO. 2 Angi-cor argues that the remaining state law claim against Angicor should be dismissed without prejudice under Gibbs.
II. DISCUSSION.
A. RICO.
1. Pattern of Racketeering Activity.
Plaintiff alleges that defendants violated all four provisions of 18 U.S.C. § 1962. Although each of the substantive provi *1003 sions, (a), (b) and (c), is directed at a particular type of conduct, the provisions have common elements of proof. Under each substantive provision, a plaintiff must allege and prove a pattern of racketeering activity. 18 U.S.C. § 1962(a), § 1962(b) and § 1962(c).
The United States Court of Appeals for the Eighth Circuit has adopted a restrictive interpretation of the pattern requirement. In addition to the universally adopted requirement that a plaintiff must allege and prove several related racketeering or predicate acts in furtherance of a single criminal scheme, the Eighth Circuit requires a plaintiff to allege and prove that a defendant has committed the same or similar racketeering activity in the past, or is engaged in other criminal activities elsewhere.
Superior Oil Co. v. Fulmer,
Although not providing a descriptive definition of what constitutes multiple schemes, the Eighth Circuit has provided a case-by-ease definition of what does not constitute multiple criminal schemes through numerous pattern cases decided since
Superior Oil. See, e.g., Holmberg v. Morrisette,
These cases instruct that numerous predicate acts occurring over a long period of time do not, standing alone, constitute multiple illegal schemes.
H.J.,
The closest the Eighth Circuit has come to providing some of the considerations involved in determining whether conduct constitutes multiple schemes was in United States v. Kragness where the court stated:
Here we think it clear that even our more restrictive view of the pattern requirement has been met, for there is evidence of not two but three separate schemes: first, there was a scheme to import marijuana into La Junta; second, there was a cocaine-and-quaalude scheme; and third, there was a scheme to import marijuana into the Phoenix area. The cocaine-and-quaalude project constitutes a separate scheme because, inter alia, it involved drugs different from that in the other schemes, a different drug supplier from a different country, a different United States base of *1004 operations (Anadarko/Chickasha), different customers, and the participation of a number of persons, such as Benanti and his associates, who were not involved in the marijuana schemes. While the La Junta and Phoenix schemes both involved marijuana from Oaxaca, Mexico, they nonetheless were separate schemes. They involved different United States bases of operation and different methods of smuggling the marijuana into the country (the La Junta marijuana was generally flown directly from Oaxaca to the United States, while the Phoenix marijuana was first driven to a point near the United States border). Further, there were a number of participants in each scheme who took no part in the other. Finally, the two schemes were separated by a substantial period of time; the last La Junta-based drug activities were in early 1981, while the earliest Phoenix activities were in mid-1982. We consequently have little difficulty in concluding that the pattern requirement was met here.
In its responsive memorandum, plaintiff lists three illegal “schemes” that it claims are separate and distinct:
1) the theft, destruction and secretion of Medical’s documents and trade secrets; 2) the use of Medical’s trade secrets to develop, market and finance a competing heart valve; and 3) the submission of false data to the United States Food and Drug Administration (“FDA”) in order to obtain the right to export certain heart valves.
Plaintiff further alleges that defendants violated 18 U.S.C. § 1341 (mail fraud), § 1343 (wire fraud), and § 2314 (transportation of stolen goods) in carrying out the first two schemes, and 18 U.S.C. § 1341 (mail fraud) in carrying out the last scheme. If proved, each of the above-mentioned alleged violations of federal statutes would constitute racketeering activity within the meaning of the RICO statute. 18 U.S.C. § 1961(1). In response to plaintiff’s allegations, both defendants assert that plaintiff has failed to allege two illegal schemes.
The court has little difficulty concluding that plaintiff’s first two alleged schemes actually constitute a single illegal scheme to misappropriate Medical’s trade secrets. Trade secrets are of little value to the person stealing them, unless that person uses the trade secrets in one way or another. The fact that defendants allegedly chose to use the trade secrets to manufacture a heart valve as opposed to selling the trade secrets to a third party does not make such conduct a separate scheme.
The FDA scheme is a closer question. If the court understands the plaintiff’s position, plaintiff argues that this conduct constitutes a separate scheme for two separate and distinct reasons. First, plaintiff argues that defendants’ fraudulent conduct in obtaining export approval for the heart valve allegedly created using Medical’s trade secrets is an expanded use of the stolen trade secrets and, therefore, a new and different scheme. For the same reasons that the first two alleged schemes are not distinct schemes, this alleged scheme merges with the two previously discussed schemes.
Alternatively, plaintiff argues that the alleged false submissions to the FDA constitutes a separate criminal scheme to defraud the United States Government. Under this scenario, the fraudulent conduct was submitting false testing data to the FDA, the victim of the fraudulent conduct was the United States, and the United States’ property interest was the granting of the export approval.
Although Angicor failed to address the issue in its memorandum, at oral argument Angicor argued that the alleged false submissions to the FDA cannot constitute racketeering activity because such conduct does not give rise to a private cause of action. While it is true that there is no private cause of action for violations of the Food, Drug and Cosmetic Act, plaintiff is not required to show that a defendant’s conduct creates a private cause of action to establish a racketeering act. Instead, rack
*1005
eteering activity is defined by the RICO statute, and included within this definition is mail fraud. Moreover, case law supports the proposition that a person can be convicted under the mail fraud statute for defrauding the United States out of money or property.
See United States v. Miller,
The more difficult aspect of the plaintiffs alleged FDA scheme is whether FDA export approval constitutes a property right within the meaning of the mail fraud statute. The mail fraud statute criminalizes schemes to defraud any number of victims, including persons, businesses, or governments. In a recent decision, however, the Supreme Court limited the scope of prohibited activities to fraudulent schemes to obtain money or property.
McNally v. United States,
— U.S. -,
In
McNally,
the Court rejected the interpretation by several lower courts that the money and property requirement of the mail fraud statute included an intangible right of the citizenry to good government. The Court reaffirmed the notion that the words “to defraud” refer “to wronging one in his property rights by dishonest methods or schemes and usually signify the deprivation of something of value by trick, deceit, chicane, or overreaching.”
Id.
Shortly after the
McNally
decision, however, the Supreme Court made it clear that it was not completely abandoning an intangible aspect to the property right requirement.
Winans v. United States,
— U.S. -,
Although admittedly a close question, the court believes the FDA’s interest in approving exports is more similar to the intangible right of the citizenry to good government than the intangible property right a business has in its confidential business information. An intangible property right is merely an interest in property which has no physical existence. Black’s Law Dictionary, 636 (5th ed. 1983). Property is anything of value. Model Penal Code § 223.0. In Winans, the exclusive use of the confidential business information contained in the Heard column was of some value to the Wall Street Journal, although the value was difficult to measure in financial terms. In McNally, the intangible right to good government was not sufficiently susceptible to valuation so as to qualify as a property right under the mail fraud statute.
The purpose of the Food, Drug and Cosmetic Act is to protect the consuming public.
See McDermott v. Wisconsin,
Consequently, the FDA does not have a cognizable property interest under the mail fraud statute in granting export approval. Hence, plaintiffs alleged FDA scheme does not constitute a second criminal scheme.
2. Enterprise Distinct From Pattern of Racketeering.
Defendant Angicor argues that plaintiff failed to allege an “enterprise”
*1006
that has an ascertainable structure distinct from that inherent in the conduct of a pattern of racketeering.
See United States v. Lemm,
3. Enterprise Distinct from Person.
The majority of the circuits, including the Eighth Circuit, have held that an entity enterprise must be distinct from the “persons” named as defendants under § 1962(c).
3
Bennett v. Berg,
Defendant Angicor apparently argues that a member of an association-in-fact enterprise cannot be a person under § 1962(a), (b) or (c), while plaintiff argues the contrary position.
Unfortunately, the Eighth Circuit has yet to pass on either of the above-mentioned controversial issues. For purposes of this motion, however, resolution of these issues by the Eighth Circuit is not critical. This is so because the facts of this case are sufficiently analogous to the facts of Berg, to bring the case within the holding of Berg, despite plaintiffs attempt to characterize the enterprise as an association-in-fact and to include as members of the enterprise numerous “co-conspirators.” The co-conspirators are merely businesses used by defendants to manufacture and sell defendants’ heart valves. There is no allegation that these “co-conspirators” were familiar with one or more of the racketeering activities. After eliminating the co-conspirators from the enterprise, the composite members of the enterprise are identical to the persons named as defendants, which is proscribed by Berg.
B. State Law Claims.
The final issue to be resolved is whether the court should retain jurisdiction over the plaintiff’s pendent state law
*1007
claims. Predictably, defendants argue that the state law claims should be dismissed while the plaintiff urges the court to retain jurisdiction. Both parties concede, however, that despite the lack of independent federal jurisdiction, it is within the court’s sound discretion to retain jurisdiction over pendant state law claims following dismissal of all federal claims.
See Rosado v. Wyman,
Based upon the record as presently constituted and the foregoing discussion,
IT IS ORDERED That:
1. The motions of defendants Angicor and Raster to dismiss plaintiff’s RICO counts with prejudice are granted.
2. The motions of defendants Angicor and Raster to dismiss without prejudice plaintiff’s pendent state law claims are granted, conditioned upon defendants filing in this court within twenty (20) days of the date of this order their consent that the statute of limitations is tolled during the pendency of this federal action on the causes of action asserted in counts III and IV.
3.The effective date of this order is stayed thirty (30) days from the date of its entry.
Notes
. Although defendant Angicor has moved for summary judgment in the alternative, it has not submitted any matters outside the pleadings that it wishes the court to consider.
. In addition, Angicor argues that plaintiff failed to plead its RICO count with sufficient particularity.
. There are two classes of enterprises: legal entity enterprises, which include individuals, partnerships, corporations, associations or other legal entities, and associations-in-fact enterprises. 18 U.S.C. § 1961(4).
